#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1054500	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
2.	ALA1054501	F	GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
3.	ALA1054502	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
4.	ALA1054503	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
5.	ALA1054504	F	GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.	Homo sapiens	13,467	ALA1157539	cell-based format	GSK Malaria Screening
6.	ALA1054505	F	GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested		13,467	ALA1157539	assay format	GSK Malaria Screening
7.	ALA1047860	F	Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum FcB1 to IC50 for drug-sensitive Plasmodium falciparum 3D7	Plasmodium falciparum	21	ALA1156797	organism-based format	Scientific Literature
8.	ALA1047861	F	Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 assessed as [3H]hypoxanthine incorporation after 48 hrs by beta-counter	Plasmodium falciparum	66	ALA1156797	organism-based format	Scientific Literature
9.	ALA1047862	A	Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay	Homo sapiens	66	ALA1156797	cell-based format	Scientific Literature
10.	ALA1047863	F	Selectivity index, ratio of CC50 for human MCF7 cells to IC50 for chloroquine-resistant Plasmodium falciparum FcB1		66	ALA1156797	cell-based format	Scientific Literature
11.	ALA1047864	F	Antimalarial activity against drug-sensitive Plasmodium falciparum 3D7 assessed as [3H]hypoxanthine incorporation by scintillation counting	Plasmodium falciparum	21	ALA1156797	organism-based format	Scientific Literature
12.	ALA1047865	F	Antimalarial activity against Plasmodium falciparum K1 assessed as [3H]hypoxanthine incorporation by scintillation counting	Plasmodium falciparum	21	ALA1156797	organism-based format	Scientific Literature
13.	ALA1047866	A	Cytotoxicity against human KB cells after 72 hrs by alamar blue assay	Homo sapiens	21	ALA1156797	cell-based format	Scientific Literature
14.	ALA1047867	F	Selectivity index, ratio of CC50 for human KB cells to IC50 for drug-sensitive Plasmodium falciparum 3D7		21	ALA1156797	cell-based format	Scientific Literature
15.	ALA1047868	F	Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for drug-sensitive Plasmodium falciparum 3D7	Plasmodium falciparum	21	ALA1156797	organism-based format	Scientific Literature
16.	ALA1050499	F	Antimalarial activity against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) assessed as reduction in parasitemia at 30 mg/kg, perorally after 3 days measured on day 4	Plasmodium berghei	4	ALA1156797	organism-based format	Scientific Literature
17.	ALA1050500	F	Antimalarial activity against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) assessed as reduction in parasitemia at 30 mg/kg, intraperitoneally after 3 days measured on day 4	Plasmodium berghei	4	ALA1156797	organism-based format	Scientific Literature
18.	ALA1050502	A	Metabolic stability in CD1 mouse liver microsomes assessed as half life	Mus musculus	5	ALA1156797	microsome format	Scientific Literature
19.	ALA3436042	F	ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro	Leishmania mexicana	13,179	ALA3433997	assay format	St Jude Leishmania Screening
20.	ALA3436043	F	ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	13,179	ALA3433997	assay format	St Jude Leishmania Screening